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Superﬁcial basal cell carcinoma and tinea nigra sometimes share similar clinical manifestations. Herein,
we report the case of a 56-year-old Asian woman with superﬁcial basal cell carcinoma located on her
philtrum, which was initially misdiagnosed as tinea nigra. We also describe the different distinguishing
features of this lesion under dermoscopic examination to improve the diagnostic accuracy. Because of the
relatively low rate of metastasis and less aggressive nature of a superﬁcial basal cell carcinoma, cosmetic
concerns should be taken into consideration in planning treatment. In this case, the patient received
photodynamic therapy that yielded an excellent clinical response over a 9-months follow-up.
Copyright  2011, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Each type of pigmented skin disease has different distinguishable
features under dermoscopic examination. In this paper, we report
the dermoscopic ﬁndings of superﬁcial basal cell carcinoma in order
to improve thediagnostic accuracy. Furthermore,weprovide a series
of clinical pictures and dermoscopic ﬁgures after photodynamic
therapy. In our experience, photodynamic therapy offers signiﬁcant
cosmetic advantages over surgical or other options, which may lead
to potentially destructive outcomes. Our case demonstrates the
success of photodynamic therapy, a viable treatment option that
does not compromise the cosmetic outcome or produce any
noticeable side effects, which can be applied in the future.Case report
A 56-year-old Asian woman came to our clinic with a well
demarcated, erythematous to brownish patch on her philtrum for
one year. The patient had been treated at a local clinic under the
diagnosis of tinea nigra for 6 months without efﬁcacy. On exami-
nation, the brownish macule was 1.4  0.8-cm in size with some
blackish dots and ﬁne scales (Figure 1A). Further dermoscopic
examinations revealed a light brown, structureless area with focal,ogy, Chang Gung Memorial
an.
.-S. Chiu).
iwanese Dermatological Associatioshiny white to red parts, some peripheral brown dots, spoke-wheel
areas, leaf-like structure, telangiectasia, and arborizing vessels
suggesting basal cell carcinoma (Figures 1BeD). Therefore, we
performed a skin biopsy and conﬁrmed the diagnosis. Given the
postoperative cosmetic concerns, the patient received methyl-
aminolevulinateebased photodynamic therapy (MAL-PDT). We
applied a 1-mmethick layer of MAL cream (Metvix 160 mg/g,
Galderma, Australia) on the lesion and 5 mm into the surrounding
margins. The area was then covered with an occlusive, nonabsor-
bent dressing and aluminum foil for 3 consecutive hours. The skin
lesion was then put under noncoherent red light (LED, Aktilite CL
16, wavelength 630 nm, Photocure ASA, Oslo, Norway) and
administered a total dose of 37 J/cm2. The patient only received one
session of MAL-PDT. Subsequent to the treatment, the patient
exhibited crusting and transient erythema on and around the
treated area, which receded spontaneously after 5 days (Figure 2A).
The brownishmacule gradually subsided in the following days with
mild skin atrophy, but there was no signiﬁcant scarring or disﬁg-
urement. After a 9-month follow-up, we did not discover any
evidence of tumor recurrence, residual erythema, or pigmentation
(Figures 2B and 2D).
Discussion
We report a case of superﬁcial basal cell carcinoma on the central
face, which had initially been misdiagnosed as tinea nigra. Super-
ﬁcial basal cell carcinoma can be mistaken for other pigmented
macules, and clinical diagnosis may not always be easy. In suchn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) Oval-shaped erythematous to brownish macule with peripheral blackish dots. (B) Dermoscopic pictures revealed a light brown structureless architecture with shiny
white to red area and some spoke-wheel pigmentation. (C) Leaf-like structure. (D) Telangiectasia and arborizing vessels. The above ﬁndings were in favor of a basal cell carcinoma.
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accuracy. For example, tinea nigra shows a homogeneous non-
melanocytic pigmented patternwith superﬁciallyﬁne,wispy lightly
brownish strands or spicules that do not follow the dermatoglyphic
lines in the irregularmacule.1,2 In contrast, the dermoscopicﬁndings
of superﬁcial basal cell carcinoma are quite different. Scalvenzi et al3
analyzed the dermoscopic features observed in 42 cases of super-
ﬁcial basal cell carcinoma. Their studies identiﬁed the presence of:
(i) shinywhite to red areas (100%), (ii) erosion (78.6%), and (iii) short
ﬁne telangiectasia (66.6%) as the main dermoscopic criteria. Other
dermoscopic features, such as, leaf-like areas, arborizing telangiec-
tasia, and blue-gray ovoid nests are not strongly associatedwith the
diagnosis of superﬁcial basal cell carcinoma. However, these
features are useful to differentiate it from other pigmented and
nonpigmented skin lesions. In the instance of non-pigmented basal
cell carcinoma, the recognition of vascular structures such as
arborizing vessels can been applied for diagnostic purposes in der-
moscopic evaluation.10 Although this vascular structure had less
diagnostic value for Asian groups than inwhite patients, they can be
used as clues for tumor recurrence.
A surgical approach to the treatment of basal cell carcinoma that
is located in the center of the face tends to be more difﬁcult than for
those in other sites. The philtrum is a particularly difﬁcult area in
which to achieve a satisfactory cosmetic and functional surgical
repair of basal cell carcinomas, as we noted in our case. The ther-
apeutic objective is to excise the clinically apparent tumor with
a margin of clinically normal-appearing skin and gain excellent
cosmetic results with minimal distortion of the vermilion border or
obliteration of the philtrum ridges. In this instance, photodynamictherapy was the treatment of choice. Photodynamic therapy
involves the activation of a photosensitizer with visible lighting so
as to create cytotoxic oxygen species and free radicals in order to
selectively destroy rapidly proliferating cells.4,5 The advantages of
photodynamic therapy are the capacity for noninvasive targeted
treatment and excellent cosmetic outcome. Tierney et al6 used
photodynamic therapy in the treatment of superﬁcial basal cell
carcinoma and achieved overall clearance rates ranging from 72% to
94%. Vinciullo et al7 performed a prospective multicenter efﬁcacy
study to evaluate the efﬁcacy and safety of photodynamic therapy
for basal cell carcinoma deﬁned as “difﬁcult to treat” (large lesions,
in the H-zone, or in patients at high risk of surgical complications);
and the complete response rate was 89% (complete response was
deﬁned as complete disappearance of all lesions, assessed visually
and by palpation, as conﬁrmed according to histology). Horn et al8
performed a similar open label multicenter study in Australia. The
3-month complete response rate for lesions was 80%, and long-
term follow-up at 60 months revealed a recurrence rate of 38%. In
summary, because of the relatively low rate of metastasis and less
aggressive nature of superﬁcial basal cell carcinoma, issues such as
cosmetic concerns should be taken into account while attempting
to select a proper treatment for any given patient.9 On the basis of
our experience, photodynamic therapy of superﬁcial basal cell
carcinoma is a highly effective and convenient therapy. After
a single treatment, 85% basal cell carcinomas showed a complete
response at a follow-up time of at least 6 months.11 Our case
demonstrated an excellent outcome after one session of methyl-
aminolevulinateebased photodynamic therapy with no discernible
sign of tumor recurrence during a 9-month follow-up.
Figure 2 (A) One week after methyl-aminolevulinate-based-photodynamic therapy (MAL-PDT) revealed mild erythema and focal crusting. (C) Dermoscopic ﬁnding, 1 week later
after MAL-PDT, the previous leaf-like area, telangiectasia, and arborizing vessels vanish, remaining faint white to red areas. (B and D) Nine-months follow-up revealed mild pinkish
erythema with slight skin atrophy. (D) Close view.
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be used during follow-up examinations for tumor recurrence in
order to prevent unnecessary surgical biopsy and subsequent scar
formation.
Very few reports in the literature today discuss the above
problems with Asian patients in mind; one goal of this paper is to
serve this particular community. We suggest more studies to be
devoted to this ﬁeld so that more patients, especially those with
Asian backgrounds, can beneﬁt in the short run.References
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